Progyny (PGNY) announced the launch of its pregnancy, postpartum, and menopause programs for global employers, available starting January 1, 2026. These offerings complement the availability of the company’s existing and marketing-leading global fertility and family building offering, providing multi-national employers with a continuum of integrated services. Progyny’s localized global expertise and member-first experience are supporting unmet needs across pivotal women’s and family life stages.
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PGNY:
- Trump Weekly: U.S. threatens China with 100% tariff over rare earth controls
- Trump Trade: Trump says cost of GLP-1 drugs to come down ‘pretty fast’
- Trump’s possible IVF action an incremental positive for Progyny, says BofA
- White House to seek to make IVF more accessible, NY Times reports
- Progyny price target raised to $25 from $23 at JPMorgan